Invictus Oncology: Financial Breakdown
Decoding financial health metrics of Invictus Oncology
Total Revenue₹27.0 Lakh28%Prev. FY
Total Expenses₹1.5 Cr+53%Prev. FY
Profit After Tax₹-1.2 Cr+-60%Prev. FY
Total Assets₹17.9 Cr+56%Prev. FY
Net Profit Margin-4.6%-26%Prev. FY
FAQs on Financials of Invictus Oncology
No. In FY15, Invictus Oncology reported a net loss of ₹1.2 Cr+, so it was not profitable.
Invictus Oncology's revenue grew 28.6% year-on-year, from ₹21.0 Lakh in FY14 to ₹27.0 Lakh in FY15.
Invictus Oncology's estimated EBITDA for FY15 was ₹-1.1 Cr+, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY15, Invictus Oncology posted revenue of ₹27.0 Lakh (up 28.6% YoY) and a net loss of ₹1.2 Cr+. Explore the full financials of Invictus Oncology here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links